An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets

被引：32
|
作者：
Kerschbaumer, Andreas [1 ,2 ]
Fenzl, Karl H. [2 ]
Erlacher, Ludwig [2 ,3 ]
Aletaha, Daniel [1 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Karl Landsteiner Inst Autoimmune Dis & Rheumatol, Kundratstr 3, A-1100 Vienna, Austria
[3] 2nd Med Dept Rheumatol Osteol & Geriatr, Kundratstr 3, A-1100 Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2016年 / 128卷 / 21-22期
关键词：
Psoriatic arthritis; Clinical aspects; Epidemiology; Treatment; Pathophysiology; RHEUMATOID-ARTHRITIS; IMMUNE REGULATION; BIOLOGIC THERAPY; CONTROLLED-TRIAL; HIGH PREVALENCE; DISEASE; PATHOGENESIS; RISK; INFLAMMATION; ENTHESITIS;
D O I：
10.1007/s00508-016-1111-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical features and comorbidities as well as current concepts of the pathophysiology and subsequent insights in novel treatment targets.
引用
收藏
页码：791 / 795
页数：5
相关论文
共 50 条
  • [31] Tremor: Clinical Features, Pathophysiology, and Treatment
    Elble, Rodger J.
    [J]. NEUROLOGIC CLINICS, 2009, 27 (03) : 679 - +
  • [32] A novel biological target for the treatment of psoriatic arthritis
    Spadaro, Antonio
    Montepaone, Monica
    Lubrano, Ennio
    [J]. IMMUNOTHERAPY, 2014, 6 (05) : 515 - 518
  • [33] Clinical potential of apremilast in the treatment of psoriatic arthritis
    Cauli, Alberto
    Porru, Giovanni
    Piga, Matteo
    Vacca, Alessandra
    Dessole, Grazia
    Mathieu, Alessandro
    [J]. IMMUNOTARGETS AND THERAPY, 2014, 3 : 91 - 96
  • [34] Defining Novel Targets for Intervention in Rheumatoid Arthritis: An Overview
    Malemud, Charles J.
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2008, 4 (04) : 214 - 218
  • [35] Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs
    McArdle, Angela
    Pennington, Stephen
    FitzGerald, Oliver
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 55 (03) : 271 - 294
  • [36] An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far
    Oliveira, Daniel G.
    Faria, Raquel
    Torres, Tiago
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1045 - 1053
  • [37] Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs
    Angela McArdle
    Stephen Pennington
    Oliver FitzGerald
    [J]. Clinical Reviews in Allergy & Immunology, 2018, 55 : 271 - 294
  • [38] Lyme carditis: Epidemiology, pathophysiology, and clinical features in endemic areas
    Rostoff, Pawel
    Gajos, Grzegorz
    Konduracka, Ewa
    Gackowski, Andrzej
    Nessler, Jadwiga
    Piwowarska, Wieslawa
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 328 - 333
  • [39] Sex differences in the epidemiology, clinical features, and CrossMark pathophysiology of migraine
    Vetvik, Kjersti Grotta
    MacGregor, E. Anne
    [J]. LANCET NEUROLOGY, 2017, 16 (01): : 76 - 87
  • [40] Clinical improvement in psoriatic nail disease and psoriatic arthritis with tildrakizumab treatment
    Ismail, Fathima F.
    May, John
    Moi, John
    Sinclair, Rodney
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (02)
12345